These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 22174580

  • 1. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D, Ferdinand K, Purkayastha D, Samuel R, Wright R.
    Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
    [Abstract] [Full Text] [Related]

  • 2. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF, Duprez D, Purkayastha D, Samuel R, Ferdinand KC.
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
    [Abstract] [Full Text] [Related]

  • 3. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis.
    Agarwal R, Weir MR.
    J Hypertens; 2013 Aug; 31(8):1692-701. PubMed ID: 23697963
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 6. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
    Destro M, Crikelair N, Yen J, Glazer R.
    Vasc Health Risk Manag; 2010 Sep 07; 6():821-7. PubMed ID: 20859551
    [Abstract] [Full Text] [Related]

  • 7. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
    Smith DH, Dubiel R, Jones M.
    Am J Cardiovasc Drugs; 2005 Sep 07; 5(1):41-50. PubMed ID: 15631537
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
    Raij L, Egan BM, Zappe DH, Purkayastha D, Samuel R, Sowers JR.
    J Clin Hypertens (Greenwich); 2011 Oct 07; 13(10):731-8. PubMed ID: 21974760
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
    Nishiwaki M, Hosoai H, Ikewaki K, Ayaori M, Yamashita T, Shige H, Higashi K, Nashida Y, Shimizu S, Kijima F, Yokoyama M, Nakamura H, ABC Study Group.
    Clin Ther; 2013 Apr 07; 35(4):461-73. PubMed ID: 23490288
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
    Giles TD, Oparil S, Ofili EO, Pitt B, Purkayastha D, Hilkert R, Samuel R, Sowers JR.
    Blood Press Monit; 2011 Apr 07; 16(2):87-95. PubMed ID: 21386706
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA.
    Ther Adv Cardiovasc Dis; 2014 Feb 07; 8(1):12-21. PubMed ID: 24492985
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of valsartan, hydrochlorothiazide, and their combination on 24-h ambulatory blood pressure response in elderly patients with systolic hypertension: a ValVET substudy.
    Duprez DA, Weintraub HS, Cushman WC, Purkayastha D, Zappe D, Samuel R, Izzo JL.
    Blood Press Monit; 2011 Aug 07; 16(4):186-96. PubMed ID: 21747241
    [Abstract] [Full Text] [Related]

  • 16. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
    Calhoun DA, Lacourcière Y, Crikelair N, Jia Y, Glazer RD.
    Curr Med Res Opin; 2013 Aug 07; 29(8):901-10. PubMed ID: 23721363
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 07; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 18. Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.
    Sharma AM, Davidson J, Koval S, Lacourcière Y.
    Cardiovasc Diabetol; 2007 Oct 02; 6():28. PubMed ID: 17910747
    [Abstract] [Full Text] [Related]

  • 19. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD.
    Hypertension; 2009 Jul 02; 54(1):32-9. PubMed ID: 19470877
    [Abstract] [Full Text] [Related]

  • 20. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS, Makris T, Papavasiliou M, Efstathiou S, Manolis A.
    J Hypertens; 2005 Apr 02; 23(4):883-9. PubMed ID: 15775795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.